82 related articles for article (PubMed ID: 17823991)
1. Smoldering multiple myeloma.
Andrews AT
N Engl J Med; 2007 Sep; 357(10):1048; author reply 1049-50. PubMed ID: 17823991
[No Abstract] [Full Text] [Related]
2. [Immunoglobulin subclasses and multiple myeloma. Clinico-biological correlations, with special reference to IgG3 myelomas (author's transl)].
San Miguel J; Hernández F; Vicente V; Recio M; López Borrasca A
Sangre (Barc); 1980; 25(6):1034-9. PubMed ID: 7221825
[No Abstract] [Full Text] [Related]
3. [Double myeloma with mediastinal involvement].
de Gracia J; Arqués P; Rodrigo MJ; Joanmiquel L; López López I; Vidal R
Med Clin (Barc); 1984 Sep; 83(9):393. PubMed ID: 6503437
[No Abstract] [Full Text] [Related]
4. [Resistance deficiency in multiple myeloma].
Spath P; Schmalzl F; Spitler LE; Petz L; Cooper N; Fudenberg HH
Haematol Blood Transfus; 1978; 21():441-3. PubMed ID: 738648
[No Abstract] [Full Text] [Related]
5. Multiple myeloma and systemic lupus erythematosus in a young woman.
Okoli K; Irani F; Horvath W
J Clin Rheumatol; 2009 Sep; 15(6):292-4. PubMed ID: 19734735
[TBL] [Abstract][Full Text] [Related]
6. [Myeloma with 2 monoclonal immunoglobulins. 10-year development].
Cauderlier P; Bardet M; Jaltel M; Luthier F; Luthier B; Josancy M; Caplan F; Benhamou C
Presse Med; 1983 Feb; 12(9):576-7. PubMed ID: 6219376
[No Abstract] [Full Text] [Related]
7. Transfusion medicine illustrated. Hyperviscosity and the prozone effect in multiple myeloma.
Costa FP; Dourado DA; Borsoi CS; Deeke CD; Valvasori M; Colella R
Transfusion; 2008 Oct; 48(10):2056. PubMed ID: 18928508
[No Abstract] [Full Text] [Related]
8. [Antigenic hererogenicity of gamma G myeloma globulins. I. Distinction of antigenic subgroups].
Madaliński K
Med Dosw Mikrobiol; 1969; 21(3):315-22. PubMed ID: 5307838
[No Abstract] [Full Text] [Related]
9. [Dysglobulinemia preceding myeloma with plasmocyte cutaneous tumors].
Degos R; Touraine R; Audebert G; Foix C
Bull Soc Fr Dermatol Syphiligr; 1970; 77(5):760-2. PubMed ID: 5518206
[No Abstract] [Full Text] [Related]
10. IgA myeloma with quadrangular crystalline inclusions.
Daneshbod Y; Kumar PV; Tabei SZ
Haematologica; 2004 Aug; 89(8):EIM18. PubMed ID: 15339699
[No Abstract] [Full Text] [Related]
11. Periodic fever as the only presenting symptom of multiple myeloma in a young man.
Trakatelli C; Kintiraki E; Koratzis J; Gamvrili L; Kotsis V; Sion M
J Biol Regul Homeost Agents; 2008; 22(4):263-5. PubMed ID: 19036229
[TBL] [Abstract][Full Text] [Related]
12. Pyoderma gangrenosum associated with subcorneal pustular dermatosis and IgA myeloma.
Ahmad K; Ramsay B
Clin Exp Dermatol; 2009 Jan; 34(1):46-8. PubMed ID: 18627386
[TBL] [Abstract][Full Text] [Related]
13. IgA Type Multiple Myeloma, Clinical Features, and Prognosis.
Wang L; Jin FY; Li Y; Sun JN; Zhang JJ; Tang R; Zhong YP
Chin Med J (Engl); 2018 May; 131(10):1249-1250. PubMed ID: 29722346
[No Abstract] [Full Text] [Related]
14. Smoldering multiple myeloma.
Focosi D
N Engl J Med; 2007 Sep; 357(10):1048-9; author reply 1049-50. PubMed ID: 17823992
[No Abstract] [Full Text] [Related]
15. [Smoldering multiple myeloma].
Kanoh T
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):422-6. PubMed ID: 9851179
[No Abstract] [Full Text] [Related]
16. Variations among gamma-globulins at the antigenic site revealed by pepsin digestion.
Williams RC; Lawrence TG
J Clin Invest; 1966 May; 45(5):714-23. PubMed ID: 5327482
[No Abstract] [Full Text] [Related]
17. Could the use of appropriate diet help in the prevention of multiple myeloma?
Juranic Z; Besu I; Dajak M; Konic-Ristic A
J BUON; 2009; 14(2):321-2. PubMed ID: 19650187
[No Abstract] [Full Text] [Related]
18. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.
Rajkumar SV; Buadi F
Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712
[TBL] [Abstract][Full Text] [Related]
19. Increased osteoblastic activity in myelomatosis.
Wong KF; So CC; Chan JK
Br J Haematol; 2000 Jul; 110(1):1. PubMed ID: 10930973
[No Abstract] [Full Text] [Related]
20. The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease.
Alcoceba M; Marín L; Balanzategui A; Sarasquete ME; Martín-Jiménez P; Chillón MC; Corral R; Pérez-Persona E; Fernández-Calvo FJ; Hernández JM; Bladé J; Lahuerta JJ; González M; San Miguel JF; García-Sanz R
Tissue Antigens; 2008 Jun; 71(6):548-51. PubMed ID: 18397187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
